Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis

NCT00287573 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00287573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00287573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Trial Evaluating Slow-Release Formulation TAXUS Paclitaxel-Eluting Coronary Stent in the Treatment of In-Stent Restenosis
Lead sponsor
Boston Scientific Corporation
Phase
Phase 2/3
Overall status
Completed
Start date
June 30, 2003
Completion date
January 31, 2010
Enrollment
488 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

coronary restenosis